Frameshift Genomics

Frameshift Genomics, founded in 2015 by Gabor Marth, Chase Miller, and Alistair Ward, is a private company based in Cambridge, USA, operating at the intersection of genetics, genomics, and AI/machine learning. The company has developed the Mosaic platform, a clinical research genomics platform that combines automated variant prioritization with powerful, collaborative visualization and analysis tools aimed at scaling genomic diagnostics. Leveraging the founders' deep expertise from the IOBIO project and large-scale genomic consortia, Frameshift targets the growing need for interpretable and shareable genomic data analysis in both clinical and research settings. Its business model is platform-based, likely generating early revenue through software access and services.

Mosaic, a cloud-based genomic data visualization and analytics platform that combines automated variant prioritization with interactive, collaborative tools for team-based exploration of genomic and phenotypic data. It features real-time querying, a versioned annotation catalog, cohort analysis, and shared workspaces.

Frameshift operates in a crowded field with competitors ranging from large incumbents like Illumina (DRAGEN, Connected Analytics) and QIAGEN (Clinical Insight) to specialized software companies like Fabric Genomics, Genomenon, and Diploid. Its key differentiator is its strong heritage in real-time, web-based visualization (from IOBIO) and a pronounced focus on enabling collaborative, interactive analysis rather than solely providing automated variant reports.